Manufacturers use bioburden testing to measure the viable microorganisms present on or in a product before sterilization. The results can influence both process control and patient safety. Sterilization receives considerable attention in healthcare manufacturing, but its effectiveness depends partly on what is present on a product beforehand. Medical devices, pharmaceutical products, and other healthcare materials can acquire microorganisms from raw materials or manufacturing environments. Equipment, handling, and packaging processes are other possible sources.
Bioburden Is More Than a Final Test Result
A bioburden result provides a snapshot of microbial contamination, but its value extends beyond a single number. Testing performed over time can reveal whether a manufacturing process remains microbiologically controlled.
An unexpected increase may point to a change somewhere upstream. In an April 30, 2026 warning letter to CareFusion 213, LLC, the U.S. Food and Drug Administration (FDA) documented a bioburden excursion involving Streptococcus pneumoniae and improper mask use. Those observations did not, by themselves, establish the source of that contamination.
For this reason, manufacturers can use bioburden data as part of routine monitoring rather than viewing testing solely as a release requirement. Trends may reveal gradual changes that individual results would make difficult to recognize.
Sterilization Processes Depend on Reliable Data
For products that will be terminally sterilized, bioburden information can contribute to sterilization process development and validation. The microorganisms present before sterilization represent the microbial challenge the process must address.
The relationship is especially important because sterilization should operate as a validated process rather than an attempt to compensate for uncontrolled manufacturing conditions. Consistently high or unpredictable microbial contamination can indicate that earlier production controls need attention.
Bioburden testing can also help establish appropriate parameters for certain sterilization validation approaches. Reliable recovery methods matter. A test that fails to recover microorganisms effectively may underestimate the actual microbial population. The International Organization for Standardization (ISO) addresses microbial enumeration and characterization on healthcare products in ISO 11737-1:2018.
The Test Method Has to Fit the Product
Microorganisms must first be removed or recovered from the test article before they can be counted. Product design and materials can affect how successfully that happens.
A tissue study by John B. Kowalski and colleagues, published online in 2011, found the highest recovery with sonication plus mechanical shaking; the researchers reported first-rinse recovery of 65% with Fluid D versus 39% with Butterfield’s buffer. Method suitability work helps determine whether the chosen procedure can recover microorganisms adequately without introducing conditions that prevent them from being detected.
Organizations using outside laboratories should still know how samples are collected and transported. Ask how the laboratory tests samples and interprets the count. Broader testing and certification services, such as Technical Safety Services’ cleanroom and biological safety cabinet testing, address controlled environments and equipment performance. A technically valid bioburden result also depends on what happened before the laboratory reported the final count.
Results Can Point Back to the Production Floor
Bioburden investigations should look beyond the affected batch. If microbial levels rise, manufacturers may need to examine environmental monitoring data and personnel practices alongside cleaning records. Incoming materials and equipment also warrant review, as do recent process changes.
Patterns can be informative. Repeated recovery of similar organisms may provide clues about where contamination is entering the process.
At your next bioburden review, ask whether a rising count lines up with a documented production change and whether the recovery method still fits the product. Use those questions to guide the investigation before treating the next acceptable count as evidence that the problem is resolved.
